AbbVie Inc. (ABBV) by event type
ABBV moves most on coverage initiations — a median of -0.28% at 30 minutes across 34 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ABBV overview →
How ABBV reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 817 of 2,717 | 47 | +0.20% | 57% | +0.14% |
| Analyst downgrades 1,443 of 2,603 | 24 | -0.01% | 50% | +0.45% |
| Coverage initiations 1,753 of 2,283 | 34 | -0.28% | 41% | -1.03% |
| Rating reiterations 1,356 of 3,522 | 161 | +0.03% | 52% | +0.07% |
| Price-target raises 379 of 1,790 | 65 | +0.12% | 60% | +0.09% |
| Price-target cuts 681 of 1,527 | 11 | +0.00% | 55% | -0.28% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how ABBV usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · ABBV overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AIMMUNE THERAPEUTICS (AIMT) | 734 | -0.29% | 40% |
| Vertex Pharmaceuticals Incorporated (VRTX) | 733 | +0.10% | 55% |
| INSYS THERAPEUTICS (INSY) | 731 | +0.00% | 50% |
| Myovant Sciences Ltd. Common Shares (MYOV) | 728 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.